NCT06561256View on ClinicalTrials.gov

JAK Inhibitors' Efficacy in Bullous Pemphigoid

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Bullous PemphigoidJanus Kinase InhibitorCorticosteroids
Interventions
DRUG

Janus Kinase Inhibitor

Janus Kinase Inhibitor in combination with corticosteroids

Trial Locations (1)

350000

The First Affiliated Hospital of Fujian Medical University, Fujian

Sponsors

Lead Sponsor

Chao Ji
All Listed Sponsors
lead

Chao Ji

OTHER